Synthroid (levothyroxine sodium tablets, USP) July 2008
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2008
|The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.|
- Drug Interactions
- Table 2
- Drugs that may decrease T4 absorption, which may result in hypothyroidism
- Patients treated concomitantly with orlistat and levothyroxine should be monitored for changes in thyroid function.
The July 2008 label not available at this site.